Fund HoldingsCaligan Partners LP

Total Portfolio Value
$378.31M
Total Bought
$76.58M
Total Sold
$20.69M
Net Transaction
+$55.88M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
LIQUIDIA CORPORATION(LQDA)10,360,94510,360,9450124,642152,82440.40%+28,182
VERONA PHARMA PLC183,0641,296,447+1,113,3833,63920,8605.51%+17,221
ENANTA PHARMACEUTICALS INC0858,070+858,070014,9823.96%+14,982
EVOLUS INC1,317,8561,888,881+571,02513,87726,4446.99%+12,567
ANIKA THERAPEUTICS INC1,081,3601,435,993+354,63324,50436,4749.64%+11,971
OUTLOOK THERAPEUTICS INC0500,000+500,00005,9701.58%+5,970
AGIOS PHARMACEUTICALS INC(AGIO)441,833484,711+42,8789,84014,1733.75%+4,333
EXELIXIS INC(EXEL)910,7301,100,730+190,00021,84826,1206.90%+4,272
BIOCRYST PHARMACEUTICALS INC(BCRX)0758,502+758,50203,8531.02%+3,853
Y-MABS THERAPEUTICS INC1,048,425587,276-461,1497,1509,5492.52%+2,399
I MAB0756,538+756,53801,4070.37%+1,407
SOCIETAL CDMO INC1,689,7680-1,689,7685920-592
ADMA BIOLOGICS INC473,0870-473,0872,1380-2,138
ALIMERA SCIENCES INC16,835,15416,835,154072,72865,65717.36%-7,071
STANDARD BIOTOOLS INC7,042,4130-7,042,41315,5640-15,564
Page 1 of 1